Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

Ardent Health Partners, Inc. (ARDT)

Compare
13.20
+0.04
+(0.30%)
At close: March 28 at 4:00:02 PM EDT
12.88
-0.32
(-2.42%)
Pre-Market: 7:01:34 AM EDT
Loading Chart for ARDT
  • Previous Close 13.16
  • Open 13.05
  • Bid --
  • Ask --
  • Day's Range 12.99 - 13.24
  • 52 Week Range 12.87 - 20.72
  • Volume 338,692
  • Avg. Volume 461,281
  • Market Cap (intraday) 1.884B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 8.35
  • EPS (TTM) 1.58
  • Earnings Date Feb 26, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 20.60

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

www.ardenthealth.com

19,200

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ARDT

View More

Performance Overview: ARDT

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ARDT
22.72%
S&P 500 (^GSPC)
5.11%

1-Year Return

ARDT
12.00%
S&P 500 (^GSPC)
6.22%

3-Year Return

ARDT
12.00%
S&P 500 (^GSPC)
21.97%

5-Year Return

ARDT
12.00%
S&P 500 (^GSPC)
119.59%

Compare To: ARDT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ARDT

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    1.88B

  • Enterprise Value

    3.61B

  • Trailing P/E

    8.35

  • Forward P/E

    7.13

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.29

  • Price/Book (mrq)

    1.67

  • Enterprise Value/Revenue

    0.60

  • Enterprise Value/EBITDA

    6.28

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.53%

  • Return on Assets (ttm)

    5.24%

  • Return on Equity (ttm)

    23.01%

  • Revenue (ttm)

    5.97B

  • Net Income Avi to Common (ttm)

    210.34M

  • Diluted EPS (ttm)

    1.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    566.7M

  • Total Debt/Equity (mrq)

    149.91%

  • Levered Free Cash Flow (ttm)

    50.07M

Research Analysis: ARDT

View More

Company Insights: ARDT

Research Reports: ARDT

View More

People Also Watch